Related Experiment Video
Updated: Nov 16, 2025

Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
Study of the physicochemical properties of drugs suitable for administration using a lymphatic drug delivery system
Ryoichi Fukumura1,2, Ariunbuyan Sukhbaatar1,2, Radhika Mishra1,2
1Laboratory of Biomedical Engineering for Cancer, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.
Abstract:
Lymph node (LN) metastasis is thought to account for 20-30% of deaths from head and neck cancer. The lymphatic drug delivery system (LDDS) is a new technology that enables the injection of drugs into a sentinel LN (SLN) during the early stage of tumor metastasis to treat the SLN and secondary metastatic LNs. However, the optimal physicochemical properties of the solvent used to carry the drug have not been determined. Here, we show that the osmotic pressure and viscosity of the solvent influenced the antitumor effect of cisplatin (CDDP) in a mouse model of LN metastasis. Tumor cells were inoculated into the proper axillary LN (PALN), and the LDDS was used to inject CDDP solution into the subiliac LN (SiLN) to treat the tumor cells in the downstream PALN. CDDP dissolved in saline had no therapeutic effects in the PALN after it was injected into the SiLN using the LDDS or into the tail vein (as a control). However, CDDP solution with an osmotic pressure of ~ 1,900 kPa and a viscosity of ~ 12 mPa⋅s suppressed tumor growth in the PALN after it was injected into the SiLN using the LDDS. The high osmotic pressure dilated the lymphatic vessels and sinuses to enhance drug flow in the PALN, and the high viscosity increased the retention of CDDP in the PALN. Our results demonstrate that optimizing the osmotic pressure and viscosity of the solvent can enhance the effects of CDDP, and possibly other anticancer drugs, after administration using the LDDS.
Insights
Optimizing solvent properties like osmotic pressure and viscosity enhances lymphatic drug delivery system (LDDS) effectiveness for treating head and neck cancer metastasis in lymph nodes (LNs). This approach improves cisplatin delivery and antitumor effects.
Area of Science:
- Oncology
- Drug Delivery Systems
- Cancer Metastasis Research
Background:
- Lymph node (LN) metastasis is a major cause of mortality in head and neck cancers.
- The lymphatic drug delivery system (LDDS) offers a novel approach for early-stage cancer treatment by targeting sentinel lymph nodes (SLNs).
- Optimal physicochemical properties of drug solvents for LDDS remain undetermined.
Purpose of the Study:
- To investigate the influence of solvent osmotic pressure and viscosity on the efficacy of cisplatin (CDDP) delivered via LDDS in a mouse model of lymph node metastasis.
- To determine the ideal physicochemical properties for solvents used in LDDS for enhanced antitumor effects.
Main Methods:
- A mouse model of lymph node metastasis was established by inoculating tumor cells into the proper axillary lymph node (PALN).
- CDDP was administered using LDDS into the subiliac lymph node (SiLN) to target the downstream PALN.
- Different CDDP solutions, including saline and optimized formulations (approx. 1,900 kPa osmotic pressure, 12 mPa·s viscosity), were tested.
Main Results:
- CDDP in saline showed no therapeutic effect in the PALN, regardless of administration route (LDDS or intravenous).
- CDDP formulated with high osmotic pressure (~1,900 kPa) and viscosity (~12 mPa·s) significantly suppressed tumor growth in the PALN when delivered via LDDS.
- High osmotic pressure facilitated lymphatic vessel dilation and drug flow, while high viscosity enhanced drug retention in the target lymph node.
Conclusions:
- Solvent osmotic pressure and viscosity are critical factors influencing the efficacy of CDDP delivered via LDDS.
- Optimized physicochemical properties of the solvent can significantly enhance the antitumor effects of CDDP and potentially other drugs administered through LDDS.
- This study provides a foundation for developing improved drug formulations for lymphatic drug delivery in cancer treatment.
Related Concept Videos
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Bioavailability Enhancement: Drug Permeability Enhancement
Biopharmaceutics and Pharmacokinetics: Overview
Factors Influencing Drug Absorption: Drug Dissolution
Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...

